Elevated levels of vascular endothelial growth factor in adults with severe dengue infection

[1]  K. Morita,et al.  Association of Mast Cell-Derived VEGF and Proteases in Dengue Shock Syndrome , 2012, PLoS neglected tropical diseases.

[2]  M. Guzmán,et al.  Tumor necrosis factor-alpha, transforming growth factor-β1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever. , 2010, Human immunology.

[3]  Y. Chan,et al.  Relationship between circulating vascular endothelial growth factor and its soluble receptors in adults with dengue virus infection: a case-control study. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[4]  Y. Poovorawan,et al.  The role of vascular endothelial growth factor leading to vascular leakage in children with dengue virus infection , 2007, Annals of tropical paediatrics.

[5]  L. P. Lounibos,et al.  Spread of the tiger: global risk of invasion by the mosquito Aedes albopictus. , 2007, Vector borne and zoonotic diseases.

[6]  S. Kalayanarooj,et al.  Virus-Induced Decline in Soluble Vascular Endothelial Growth Receptor 2 Is Associated with Plasma Leakage in Dengue Hemorrhagic Fever , 2006, Journal of Virology.

[7]  E. Harris,et al.  Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis , 2006, Journal of Virology.

[8]  D. Vaughn,et al.  Dengue: an escalating problem , 2002, BMJ : British Medical Journal.

[9]  Susana Vázquez,et al.  Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. , 2002, Revista panamericana de salud publica = Pan American journal of public health.

[10]  N. White,et al.  Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? , 2001, The Journal of infectious diseases.

[11]  Duane J. Gubler,et al.  Dengue and Dengue Hemorrhagic Fever , 1998, Clinical Microbiology Reviews.

[12]  Gubler Dj.  The global pandemic of dengue/dengue haemorrhagic fever: current status and prospects for the future. , 1998 .

[13]  D. Gubler,et al.  Community involvement in the control of Aedes aegypti. , 1996, Acta tropica.

[14]  N. Grist,et al.  Aedes and dengue , 1994, The Lancet.

[15]  N. Grist.  Aedes albopictus: the tyre-travelling tiger. , 1993, The Journal of infection.

[16]  R. Lanciotti,et al.  Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction , 1992, Journal of clinical microbiology.

[17]  R. Rico-Hesse,et al.  Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. , 1990, Virology.

[18]  S. Halstead,et al.  Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. , 1989, Reviews of infectious diseases.

[19]  S. Halstead,et al.  Pathogenesis of dengue: challenges to molecular biology. , 1988, Science.

[20]  S. Halstead.  Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. , 1970, The Yale journal of biology and medicine.

[21]  Anita Chakravarti,et al.  Circulating levels of tumour necrosis factor-alpha & interferon-gamma in patients with dengue & dengue haemorrhagic fever during an outbreak. , 2006, The Indian journal of medical research.

[22]  C. Ker,et al.  Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever. , 2005, FEMS immunology and medical microbiology.

[23]  D. Gubler.  The global pandemic of dengue/dengue haemorrhagic fever: current status and prospects for the future. , 1998, Annals of the Academy of Medicine, Singapore.

[24]  A. Sabin.  Research on dengue during World War II. , 1952, The American journal of tropical medicine and hygiene.

[25]  K. Shitara,et al.  and surface marker for the lineage of monocyte-macrophages in humans Flt-1 , vascular endothelial growth factor receptor 1 , is a novel cell , 2001 .